About Ligo Biosciences
We are building the next generation of deep-learning models for enzyme design to slash the cost of chemical manufacturing. The $6 trillion chemical industry is flawed: It produces 20% of industrial greenhouse gases, and is responsible for 15% of global energy usage.
Enzymes offer a far more sustainable alternative to chemical synthesis and have already revolutionised how a select few chemicals are produced. The problem is each enzyme takes years of trial and error to develop. Our enzyme models learn the principles of catalysis, allowing us to design enzymes for each reaction, in days not years.
Company details
Funding
Total raised
$500K
Last stage
Seed
Investors
Founders
Arda Goreci
Founder at Ligo (S24). I studied Cell and Systems Biology at Oxford where I became a Google Cloud Research Innovator for my work in computational biology. Interested in deep learning, scaling laws, geometric DL, biomolecular design.
Edward Harris
Studied Computer Science at Princeton before transferring to Oxford Medical School, worked across three synthetic biology labs. Second-time founder who bootstrapped his first startup at 19 to $1M in annual revenue.
LinkedIn
Emily Egerton-Warburton
Biochemist from Oxford University with experience in biotech startups, working on projects from bacterial biofuel production to vaccine design.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.